Fundraising Fox
Kinaset Therapeutics
Medfield, US · Founded 2020 · Delaware corporation · 17 employees on LinkedIn · 13 known investors
Find your way into Kinaset Therapeutics
Sign up to find every way you can get introduced to Kinaset Therapeutics
- Your email: who you already know at Kinaset Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kinaset Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation. The company is advancing toward clinical trials.
Founders & leadership
Kinaset Therapeutics was founded in 2020 by Roger Heerman, Frazer Morgan, and Robert Clarke.
Board
Investors · 13
How we know: 5AM Ventures's portfolio page · the company's own site · finance.yahoo.com · Not right? Tell us
How we know: Atlas Venture's portfolio page · the company's own site · finance.yahoo.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · the company's own site · funding news · salestools.io · Not right? Tell us
How we know: the company's own site · salestools.io · Not right? Tell us
How we know: Gimv's portfolio page · finance.yahoo.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Sixty Degree Capital's portfolio page · finance.yahoo.com · Not right? Tell us
How we know: Vivo Capital's portfolio page · salestools.io · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$133M disclosed across 3 rounds · 2020–2026
- $103MSeries BJan 2026 · 3 sources
Forge Life Science Partners (lead), RA Capital Management (lead), 5AM Ventures, Atlas Venture, EQT Life Sciences, Gimv, Pictet Alternative Advisors, Schroders Capital, Sixty Degree Capital, Vivo Capital, Willett Advisors
Source ↗
▶$28.5MraisedJul 2023 · 3 investors · PharmaceuticalsRule 506(b)
- Tom KingDirector
- Jamil BegDirector
- Robert ClarkeExecutive Officer, Director, Promoter
- Bram VanparysDirector
- Frazer MorganExecutive Officer, Promoter
- Kevin BittermanDirector
- Roger HeermanExecutive Officer, Promoter
- Offering amount
- $41M
- Amount sold
- $28.5M
- Minimum investment
- $7.1M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.5MraisedAug 2020 · 3 investors · PharmaceuticalsRule 506(b)
- Jamil BegDirector
- Tom KingDirector
- Roger HeermanExecutive Officer, Promoter
- Kevin BittermanDirector
- Frazer MorganExecutive Officer, Promoter
- Bram VanparysDirector
- Robert ClarkeExecutive Officer, Director, Promoter
- Offering amount
- $40M
- Amount sold
- $1.5M
- Minimum investment
- $375K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Kinaset Therapeutics went on to found or lead other companies.
Related companies · 5
Companies working in the same space as Kinaset Therapeutics.
In the news
Frequently asked questions
- What does Kinaset Therapeutics do?
- Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation. The company is advancing toward clinical trials.
- Who founded Kinaset Therapeutics?
- Kinaset Therapeutics was founded by Roger Heerman, Frazer Morgan, Robert Clarke in 2020.
- Who are Kinaset Therapeutics's investors?
- Kinaset Therapeutics's investors include 5AM Ventures, Atlas Venture, RA Capital, EQT Life Sciences, Gimv, Sixty Degree Capital, Vivo Capital, Inkef and 2 more.
- How much funding has Kinaset Therapeutics raised?
- Kinaset Therapeutics has disclosed $133M raised across 3 rounds.
- Where is Kinaset Therapeutics headquartered?
- Kinaset Therapeutics is headquartered in Medfield, US.